• Why lecanemab is the 'real deal' in the fight against Alzheimer's

    1 month ago - By Daily Mail

    Experts have hailed the lecanemab as 'beginning of the end' for Alzheimer's after the drug was found to slow cognitive decline by more than a quarter in clinical trials in America, Europe and Asia.
    Read more ...

     

  • Alzheimer's Drug Slows Decline, Trial Data Show

    Alzheimer's Drug Slows Decline, Trial Data Show

    1 month ago - By MedPageToday

    Treatment with the investigational anti-amyloid agent lecanemab led to modestly less decline on cognitive and functional measures in the phase III CLARITY AD trial of early Alzheimer's disease, but was associated with adverse...
    Read more ...